Giving Harvoni to patients with the more aggressive genotype 3 strain of the disease who have cirrhosis and previous drug treatment would cost a much bigger £105,761, according to NICE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback